Capivasertib T1920
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Capivasertib (AZD5363) is a new-type orally available inhibitor of the serine/threonine protein kinase AKT (IC50s: 3/7/7 nM for Akt1/2/3).
CAS nr:
1143532-39-1
Purity:
98%
Molecular Weight:
428,92
SMILES:
NC1(CCN(CC1)c1ncnc2[nH]ccc12)C(=O)N[C@@H](CCO)c1ccc(Cl)cc1
Formula:
C21H25ClN6O2
Pathway:
PI3K/Akt/mTOR signaling,Tyrosine Kinase/Adaptors,Cytoskeletal Signaling,PI3K/Akt/mTOR signaling,Autophagy
Target:
mTOR,PKA,Akt,Akt,Autophagy
